Multiple Sclerosis - Stem Cell-Derived Brain Organoids on Ax-3 Mission Seek to Improve Modeling for Neurodegenerative Diseases
Can't see this email? View it online
   
  Multiple Sclerosis  
  The latest multiple sclerosis news from News Medical  
 

Modeling neuro-immunity in Multiple SclerosisModeling neuro-immunity in Multiple Sclerosis

Watch this free webinar to learn how Charles River's CNS experts use translational assays and endpoints to examine therapeutic efficacy in the EAE immunity model of multiple sclerosis.

Watch Webinar On Demand
 
   Stem Cell-Derived Brain Organoids on Ax-3 Mission Seek to Improve Modeling for Neurodegenerative DiseasesStem Cell-Derived Brain Organoids on Ax-3 Mission Seek to Improve Modeling for Neurodegenerative Diseases
 
More than 5 million people worldwide are living with neurodegenerative disorders like Parkinson’s disease and primary progressive multiple sclerosis (PPMS).
 
   New MRI method enables early detection and better monitoring of multiple sclerosisNew MRI method enables early detection and better monitoring of multiple sclerosis
 
Multiple sclerosis (MS) is a neurological disease that usually leads to permanent disabilities. It affects around 2.9 million people worldwide, and around 15,000 in Switzerland alone.
 
   Multi-level network analysis provides integrated view of multiple sclerosisMulti-level network analysis provides integrated view of multiple sclerosis
 
International research led by the Department of Medicine and Life Sciences (MELIS) at Pompeu Fabra University, in collaboration with Hospital del Mar, Hospital Clínic, Charité - Medical University of Berlin, and the universities of Oslo and Genoa, has developed a computational biology tool, based on multi-level network analysis, to achieve an integrated vision of multiple sclerosis.
 
   Study finds the risk of recurrence of active disease in older patients with MS after discontinuing therapyStudy finds the risk of recurrence of active disease in older patients with MS after discontinuing therapy
 
An article published today in the journal Lancet Neurology evaluates the risk of recurrence of active disease in older patients with multiple sclerosis after discontinuing disease-modifying therapies.
 
   Study identifies genetic variant that increases disease severity in multiple sclerosisStudy identifies genetic variant that increases disease severity in multiple sclerosis
 
A study of more than 22,000 people with multiple sclerosis (MS) has for the first time identified a genetic variant associated with faster progression of the disease, an accumulation of disability that can rob patients of their mobility and independence over time.
 
 
    MediKnowledge - Your new AI assistant for trusted Medical Knowledge - is now live in the GPT Store.MediKnowledge - Your new AI assistant for trusted Medical Knowledge - is now live in the GPT Store.
 

Use this GPT to search for edited and trustworthy references, articles, and equipment reviews from over 20 years of trusted medical and healthcare content.

Currently only available to ChatGPT Plus account holders.

 
Ask a Question Now
 
 
 

How would you rate today's newsletter?